Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
エストラ−1,3,5(10),16−テトラエン−3−カルボキサミド誘導体、それらの製造方法、それらを含む医薬製剤および医薬を製造するためのそれらの使用
Document Type and Number:
Japanese Patent JP5791810
Kind Code:
B2
Abstract:
The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.

Inventors:
Ulrich Bothe
Naomi Barack
Matthias Bouzemann
Oliver Martin Fisher
Andrea Rothgeri
Isabella Gashav
Ingo Hartung
Tobias Markwald
Application Number:
JP2014532337A
Publication Date:
October 07, 2015
Filing Date:
September 24, 2012
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Bayer Intellectual Property GmbH
International Classes:
C07J43/00; A61K31/58; A61K45/00; A61P3/04; A61P11/00; A61P13/08; A61P15/00; A61P15/08; A61P17/08; A61P17/10; A61P17/14; A61P25/04; A61P29/00; A61P35/00; A61P43/00
Domestic Patent References:
JP7505377A
Foreign References:
WO2008065100A1
WO2005089256A2
US6541463
Other References:
ACS P. et al.,Steroids,2011年,Vol.76,p.280-90
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe